MedTrace Logo

Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis

NCT00794976 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2015-05-13

No results posted yet for this study

Summary

The objective of this study is to determine the safety and efficacy of a dexamethasone iontophoretic transdermal patch for the treatment of pain associated with lateral epicondylitis (tennis elbow).

Conditions

  • Lateral Epicondylitis
  • (Tennis Elbow)

Interventions

DRUG

Dexamethasone Iontophoretic Patch (low dose)

DRUG

Dexamethasone Iontophoretic Patch (high dose)

DRUG

Dexamethasone Passive Patch

DRUG

Placebo Patch

Sponsors & Collaborators

  • ResearchPoint

    collaborator INDUSTRY

  • Travanti Pharma Inc.

    lead INDUSTRY

Principal Investigators

  • Robert Arnold · Travanti Pharma Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00794976 on ClinicalTrials.gov